Phase II study of a human anti-interleukin (IL)-12/IL-23 monoclonal antibody in the treatment of psoriasis

被引：0
|
作者：
Langely, RG
Lebwohl, M
Leonardi, C
Yeilding, N
Guzzo, C
Wang, Y
Dooley, L
Krueger, GG
机构：
[1] Dalhousie Univ, Halifax, NS B3H 3J5, Canada
[2] Mt Sinai Sch Med, New York, NY USA
[3] St Louis Univ, St Louis, MO 63103 USA
[4] Centocor Inc, Malvern, PA 19355 USA
[5] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT 84112 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2005年 / 125卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
407
引用
收藏
页码：A69 / A69
页数：1
相关论文
共 50 条
  • [1] Results of a phase II study of a human anti-interleukin (IL)-12/IL-23 monoclonal antibody in the treatment of psoriasis
    Langley, R
    Lebwohl, M
    Leonardi, C
    Yeilding, N
    Guzzo, C
    Wang, Y
    Dooley, L
    Krueger, GG
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (01) : A6 - A6
  • [2] Subcorneal pustular dermatosis: a case series. Novel treatment with an anti-interleukin (IL)-12/IL-23 agent
    Salmon, N.
    McKay, D.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (04) : E286 - E286
  • [3] ABT-874, a fully human monoclonal anti-IL-12/IL-23 antibody for the potential treatment of autoimmune diseases
    Ding, Changhai
    Xu, Jianhua
    Li, Jun
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2008, 9 (05) : 515 - 522
  • [4] BRIAKINUMAB Human Anti-IL-12/23 Monoclonal Antibody Treatment of Psoriasis Treatment of Crohn's disease
    Crowley, Jeffrey J.
    DRUGS OF THE FUTURE, 2011, 36 (04) : 267 - 271
  • [5] Treatment of psoriasis vulgaris exacerbated by immunotherapy with the interleukin-23 (IL-23) antibody tildrakizumab
    Koutra, E.
    Angela, Y.
    Gutzmer, R.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 88 - 88
  • [6] Predicting response to anti-interleukin 12/23 treatment in psoriasis
    Wu, K. C. P.
    Reynolds, N. J.
    BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (02) : 240 - 241
  • [7] A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis
    Krueger, Gerald G.
    Langley, Richard G.
    Leonardi, Craig
    Yeilding, Newman
    Guzzo, Cynthia
    Wang, Yuhua
    Dooley, Lisa T.
    Lebwohl, Mark
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (06): : 580 - 592
  • [8] Interleukin 12/23 monoclonal antibody in the treatment of psoriasis
    Heller, Marissa
    JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (04) : 417 - 417
  • [9] Interleukin (IL)-36γ induces IL-23 production and angiogenesis in psoriasis
    Bridgewood, C.
    Fearnley, G.
    Keszegpal, A.
    Laws, P.
    Ponnambalam, S.
    Graham, A.
    Stacey, M.
    Wittmann, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (05) : E291 - E291
  • [10] Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer
    Yan, Juming
    Smyth, Mark J.
    Teng, Michele W. L.
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2018, 10 (07):
12345